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Abstract Guinea pig neutrophils contain the antimicrobial cationic peptides GNCP-1 and GNCP-2 in the granules. To understand the regulation 
of the gene expression, the promoters for the GNCP-1 and GNCP-2 genes were characterized. Sequencing analysis of the genomic clones showed 
that the nucleotide sequences of the 5’-upstream regions (1.7 kb) from exon 1 were homologous @O-93%) between the GNCP-1 and GNCP-2 genes. 
However, transient transfection assays using luciferase reporter g ne constructs revealed that the promoter activity of GNCP-1 was 2-fold greater 
than that of GNCP-2. Furthermore, DNase I footprint analysis demonstrated that three regions (I, II and III) were protected on the GNCP-1 
promoter, whereas only two protected regions (II and III) were identified on the GNCP-2 promoter. Together these observations indicate that 
GNCP-1 and GNCP-2 are encoded by homologous genes, but the expression f the GNCP-1 and GNCP-2 genes is likely to be different at the level 
of transcription. 
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1. Introduction 
Neutrophils play a central role in protecting hosts against 
microbial infections. The antimicrobial systems of neutrophils 
can be divided into two categories [l-3]. One is the oxygen- 
dependent mechanism in which H,Os, 0; and HOC1 are in- 
volved [l]. The other is the oxygen-independent mechanism in 
which granular antimicrobial proteins and peptides are in- 
volved [2,3]. The most abundant of these granular antimicrobial 
components is the low molecular-weight cationic peptide defen- 
sin, which shows potent microbicidal activities against bacteria, 
fungi and viruses [4]. 
In the previous study [5], we have purified two structurally 
homologous cationic peptides, GNCP-1 and GNCP-2, from 
guinea pig neutrophils, and found that both peptides are single- 
chain polypeptides comprising 31 amino acid residues, which 
differ by only one amino acid substitution at position 21 
(isoleucine vs. leucine). Furthermore, we have isolated three 
kinds of cDNA clones (GNCP-lA, GNCP-1B and GNCP-2) 
encoding GNCP-I and GNCP-2 [6,7]. The nucleotide se- 
quences of these cDNAs are highly homologous (99%), and the 
deduced amino acid sequences have shown that the precursor 
proteins encoded by GNCP- 1A and GNCP-1B cDNAs differ 
by only one amino acid substitution in the propeptide region, 
whereas the precursor proteins encoded by GNCP-1B and 
GNCP-2 cDNAs differ by only one amino acid substitution in 
the mature peptide region. Recently, we have isolated four 
different genomic clones, encoding GNCP-1A (clone 5), 
GNCP-1B (clone lo), and GNCP-2 cDNAs (clones 16 and 22) 
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[8,9]. The nucleotide sequences of these genomic clones are 
highly homologous (97%) in the region sequenced, and South- 
ern blot analysis of the guinea pig genomic DNA have revealed 
that clones 5 and 10, and clones 16 and 22 represent he alleles 
of the GNCP-1 and GNCP-2 genes, respectively [9]. Thus, 
GNCP-1 and GNCP-2 are encoded by homologous but differ- 
ent genes. 
It has been shown that the GNCP genes are transcribed by 
the neutrophil precursor cells in the bone marrow but not by 
the mature neutrophils, indicating that the GNCP genes are 
expressed uring a limited period of neutrophil maturation. 
However, the mechanism(s) controlling expression of the 
GNCP gene remains unknown. In this study, therefore, to 
understand the transcriptional regulation of the GNCP genes, 
we have characterized the promoters for the GNCP-1 and 
GNCP-2 genes using the genomic clones previously isolated. 
2. Mate&Is and methods 
2.1. DNA sequencing 
The 5’-flanking regions of the GNCP genes were sequenced using 
four different genomic clones encoding GNCP- 1A (clone 5), GNCP- 1 B 
(clone lo), and GNCP-2 cDNAs (clones 16 and 22) which had been 
isolated from a guinea pig genomic library [9]. Selected restriction 
fragments of the genomic DNA inserts were subcloned into the plasmid 
vector pBluescriut SK(-) (Strataaene, CA). and the nucleotide se- 
quences of the DNA fragments w&e determined from both directions 
with sequence-specific oligonucleotide primers by the dideoxy chain- 
termination procedure [lo], using the Taq Dye Deoxy Terminator Cycle 
Sequencing ICit and the 373A DNA Sequencer (Applied Biosystems, 
Inc., CA). 
2.2. Plasmid construction 
The 1.7-kb fragments and a series of deletion mutants of the 
5’-flanking regions of the GNCP genes were synthesized by polymerase 
chain reaction (PCR) using the sequence-specific sense and antisense 
primers containing an Ml;1 site and a XhbI site, respectively, at the 
5’ end. The PCR products were digested with MZuI and XhoI, and 
subcloned into the MIuI/tioI sites upstream from the luciferase gene 
in the promoterless and enhancerless PGV-B vector (PicaGene Basic 
Vector; Toyo Ink MFG Ltd., Tokyo). The sequences of the PCR 
fragments were confirmed by dideoxy sequencing. The pSV+alacto- 
sidase vector containing an SW0 promoter and enhancer (,Promega 
All rights reserved. 
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Fig. 1. Schematic structures of the GNCP genomic clones. The 15-20 
kh Sun DNA inserts of the GNCP genomic lones 5, lo,16 and 22 were 
isolated from a size-fractionated genomic library in the vector EMBL3 
[9]. Exons are shown by the numbered boxes. Filled areas indicate the 
coding regions, and the open areas depict the 5’- or 3’-untranslated 
regions of the GNCP cDNAs. Clone 5 encodes GNCP-1A cDNA 
(GAA, glutamic acid-’ and ATC, isoleucine*‘), clone 10 encodes 
GNCP-1B cDNA (CAA, glutamine-* and ATC, isoleucine”), and 
clones 16 and 22 encode GNCP-2 cDNA (CAA, glutaminee8 and CTC, 
leucine2’). These clones encode the precursor proteins comprising 93 
amino acid residues, and their amino acid sequences are the same except 
for glutamic acid-8/glutamine-8 in the propeptide and isoleucine*‘/leuc- 
ine2’ in the mature peptide [7,9]. Restriction sites: B, BarnHI; E, EcuRI; 
H, HindIII; S, S&I. SalI sites at both ends are derived from the vector. 
Horizontal arrows indicate the direction and length of the nucleotide 
sequence determined from each primer. 
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Corp., WI) was used as an internal standard for transfection efficiency, 
and the PGV-P luciferase vector (PicaGene Promoter Vector; Toyo 
Ink) containing an SV40 promoter was used as a positive control for 
each transfection. 
2.3. Cell culture, transient transfection and h&erase assays 
The cell line 104Cl (female, fetal guinea pig, transformed; ATCC 
CRL1405) was obtained from the Japanese Cancer Research Resources 
Bank (JCRB, Tokyo), and maintained in RPM1 1640 (Nissui Seiyaku 
Ltd., Tokyo) supplemented with 10% fetal calf serum. Nuclear run-off 
transcription assay [ll] has revealed that 104Cl cells are constitutively 
transcribing the GNCP genes (data not shown). The 104Cl cells (60- 
80% confluent) in 60-mm tissue culture dishes were transfected with SJ 
pg of an appropriate luciferase construct and 4pg of pSV-p-galactosi-J 
dase vector using 30 pg of the cationic lipid N-[l-(2,3- 
dioleoyloxy) propy&N,N,N-trimethyl-ammoniummethylsulfate (DOTAP; 
Boehringer Mannheim GmbH, Germany)[l2] for 6 h in 6 ml of Dul- 
becco’s modified Eagle’s medium (DMEM; Nissui Seiyaku) without 
serum. After transfection, the cells were cultured in DMEM supple- 
mented with 10% fetal calf serum for an additional 48 h, and then lysed 
in 25 mM Tris-phosphate, pH 7.8, 2 mM dithiothreitol, 2 mM 1,2- 
diaminocyclohexane-N,N,N’,N’-tetraacetic ac d, 10% glycerol and 1% 
Triton X-100. Cell lysates were assayed for the luciferase and/?-galacto- 
sidase activities using the PiCaGene Luciferase Assay System (Toy0 
Ink) [13] and the Galacto-Light system (Tropix Inc., MA) [13,14], 
respectively, inan LS 3801 liquid scintillation counter (Beckman Instru- 
ments, CA) equipped with the single photon monitor. Luciferase activ- 
ities in the lysates were normalized to theg-galactosidase activities, and 
expressed as percentages of those transfected with PGV-P vector. 
2.4. Nuclear extract preparation 
Nuclear extracts were prepared from 104Cl cells and guinea pig 
neutrophils (> 95% pure) [I 11, according to the method of Schreiber et 
al. [15], and dialyzed against 20 mM HEPES, pH 7.9, 10% glycerol, 
100 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, 0.5 mM PMSF and 
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1 PM pepstatin A. Protein concentrations were determined using the 
BCA Protein Assay Reagent (Pierce Chemical Co., IL) and bovine 
serum albumin standards. 
2.5. DNase I footprint analysis 
The DNA fragments (bp -358 to -80 and bp -223 to +47 of the 
GNCP-I and GNCPZ genes) were synthesized by PCR using sequence- 
specific sense and antisense primers containing an MIuI site at one end, 
and a XhoI site at the other, and used to make the probes. To label the 
coding strand, the DNA fragments were digested with XhoI, and end- 
labeled by filling the XhoI site with the Klenow fragment of DNA 
polymerase I and [a-3zpldCTP (>3,OOOCi/mmol; ICN Biomedicals Inc., 
CA). The labeled DNA was further digested with MluI. For the non- 
coding strand, the DNA fragments were digested with MluI, end-la- 
beled, and digested with XhoI. The probes were purified using Quick 
Spin columns (Boehringer Mannheim Corp., IN). Labeled DNA (ap- 
proximately 5 ng, 5 x 10’ cpm/pg) was incubated with nuclear extracts 
(SO-80 ,ug) on ice for 60 min in a 50 ,KI binding mixture containing 20 
mM HEPES, pH 7.9,50 mM KCl, 5 mM MgCl,, 10% glycerol, 4 c(g 
of double-stranded poly(dI-dC) (Pharmacia P-L Biochemicals Inc., 
WI), 0.5 mM EDTA, 1 mM dithiothreitol and 0.5 mM PMSF. The 
DNA was then digested with DNase I (8-300 ng; Takara Shuzo Ltd., 
Shiga) at room temperature for 90 s, and the reaction was terminated 
by the addition of 100 ~1 of stop solution (20 mM Tris-HCl, pH 7.5, 
20 mM EDTA, 0.2% sodium dodecyl sulfate, 40 &ml sheared salmon 
sperm DNA and 200 &ml proteinase K) and subsequent incubation 
at 37°C for 30 min. DNA was puritied by phenol/chloroform extraction 
and ethanol precipitation, and resolved on an 8% polyacrylamide, 8 M 
urea sequencing el. Chemical sequencing reaction cleaving at purine 
residues (A+G) was performed on each probe to make the sequence 
markers 1161. 
3. Results and discussion 
As shown in Fig. 1, four different genomic clones encoding 
GNCP-1 and GNCP-2 have been isolated from a guinea pig 
genomic library. Clone 5, encoding GNCP-IA, clone 10, encod- 
ing GNCP-lB, and clones 16 and 22, encoding GNCP-2, have 
been shown to represent he alleles of the GNCP- 1 and GNCP- 
2 genes, respectively [9]. To characterize the promoters of the 
GNCP genes, the regions upstream from exon 1 were se- 
quenced up to 1.7 kb (Fig. 2). The nucleotide sequences of clone 
5 and 10, and clones 16 and 22 were highly homologous (> 99%) 
in the region sequenced, and the homology between clones 5/10 
and clones 16/22 was 90-93%. Next, to evaluate the promoter 
activity, the 1.7-kb fragments of the S-flanking regions of the 
GNCP-1 and GNCP-2 genes were fused to the luciferase gene 
and used in the transient transfection. All the GNCP-luciferase 
constructs containing the 1.7-kb upstream fragments of the 
GNCP-1 and GNCP-2 genes reproducibly expressed > 20-fold 
more luciferase activities than the promoterless and enhancer- 
less PGV-B vector (Fig. 3). Interestingly, the luciferase con- 
structs containing the 1.7-kb upstream sequences of the GNCP- 
1 gene (clones 5 and 10) consistently showed 2-fold greater 
promoter activities than the constructs containing the 1.7-kb 
upstream sequences of the GNCP-2 gene (clones 16 and 22). To 
further localize the regulatory element(s) in the GNCP promot- 
ers, a series of S-deleted promoter fragments were fused to the 
luciferase gene and used in the transient transfection. No signif- 
icant alterations in the promoter activities were observed when 
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Fig. 3. Promoter activities of the 5’-flanking regions of the GNCP-1 and 
GNCP-2 genes. The 1.7-kb fragments (- 1.7 kb to +47 bp) and a series 
of the deletion mutants of the GNCP-1 and GNCP-2 genes were in- 
serted upstream of the luciferase gene of the promoterless and en- 
hancerless PGV-B vector (Luc). The stippled boxes upstream of the 
luciferase gene represent sequences of exon 1 (+1 to +47 bp, where +1 
denotes the previously identified transcription start site [9]). The nucle- 
otide sequences of clones 5/10 (GNCP-1 gene) and clones 16/22 
(GNCP-2 gene) were the same in the regions from -358 to -1 bp, 
respectively. Therefore, the deletion mutants common to each gene 
were synthesized and used in the transfection assay. PGV-P luciferase 
vector containing an SV40 promoter was used as a positive control. An 
appropriate luciferase construct was co-transfected with pSV-j-galac- 
tosidase vector, an internal standard for transfection efficiency, into the 
guinea pig 104Cl cells using DOTAP. After 48 h of incubation, the cell 
extracts were assayed for the luciferase and /I-galactosidase activities. 
Following normalization for transfection efficiency, the luciferase ac- 
tivities were expressed as percentages of those with PGV-P vector. Data 
represent he mean * S.D. of 3-7 separate xperiments. Regions I, II 
and III correspond to the sequences identified by DNase I footprinting 
(Figs. 4 and 5). The mutations are indicated by an X, the sequences of 
region I (-213 to -191 bp) and region II (-180 to -164 bp) of the 
GNCP-1 promoter were replaced with the GNCP-2 sequence and the 
irrelevant sequence (ATGCACTGGATCGCATC), respectively, by 
PCR using the specific primers, and the DNA fragments containing the 
mutated sequences were fused to the PGV-B vector for the transfection 
assay. DNase I footprint analysis indicated that the mutated regions I 
and II of the GNCP-1 promoter were not protected from DNase I 
digestion by the 104Cl nuclear extracts (data not shown). 
the sequences between - 1.7 kb and -224 bp were deleted from 
the GNCP-1 promoter. However, the deletion of the region 
between -223 and -80 bp resulted in the reduction of the 
t 
Fig. 2. The nucleotide sequences of the 5’-flanking regions of the GNCP-1 and GNCP-2 genes. The nucleotide sequences of clone 5 numbered from 
the putative transcription start site (marked with an asterisk) are shown. The transcription start site had been determined by primer extension analysis 
[9): Nucleotides comprising exons are in upper-case letters, and those comprising the S-flanking regions are in lower-case letters. The sequences of 
clones 10, 16 and 22 are also shown for comparison, and the sequences identical with those of clone 5 are shown by dashes. Asterisks are inserted 
to maximize the homology. 
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Fig. 4. DNase I footprint analysis of the GNCP-1 and GNCP-2 promoter regions (I). The coding and non-coding strands of the 279-bp fragments 
(-358 to -80 bp) of the GNCP-1 (A) and GNCP-2 (B) promoters were end-labeled, and incubated on ice for 60 min in the absence (control) or the 
presence of 104Cl (50,cg) or neutrophil(80 g) nuclear extracts. The DNA was digested with 8 ng (control), 200 ng (104Cl) or 300 ng (neutrophil) 
of DNase I for 90 s, and the products were analyzed on an 8% sequencing gel. A+G is a marker produced by purine-specific Maxam-Gilbert 
sequencing reaction. The sequences protected by the WC1 nuclear extracts are indicated with vertical ines. Arrowheads indicate DNase I 
hypersensitive sites. 
promoter activity to the levels of the GNCP-2 promoters. Fur- 
ther deletion to - 1 bp markedly decreased the promoter activ- 
ity to the level of PGV-B. In contrast, the promoter activities 
of GNCP-2 were not changed by the deletion of the region 
between -1.7 kb and -80 bp. The deletion of the GNCP-2 
promoter to -1 bp resulted in the almost complete loss of the 
luciferase activity, as observed with the GNCP-1 promoter. As 
seen in Fig. 2, the nucleotide sequences of the GNCP-1 and 
GNCP-2 genes are the same in the regions from -79 to - 1 bp, 
whereas there are several variations in the nucleotide sequences 
in the regions from -223 to -80 bp. These observations indicate 
that the -79 to -1 bp regions likely contain the common se- 
quences which are required for the promoter activities of both 
GNCP-1 and GNCP-2, while the -223 to -80 bp regions ap- 
pear to contain the sequences which are involved in the differ- 
ence in the promoter activities of GNCP-1 and GNCP-2. 
To determine the promoter sequences which interact with 
any nuclear proteins, DNase I footprint analysis was performed 
using the upstream fragments of the GNCP genes (the 279-bp 
fragments from -358 to -80 bp and the 270-bp fragments from 
-223 to +47 bp) and nuclear protein extracts prepared from 
104Cl cells and mature neutrophils. As shown in Figs. 4A and 
5A, three protected regions (I-III) were identified on both the 
coding and non-coding strands of the GNCP-1 promoter using 
the 104Cl cell nuclear proteins. Region I spanned from -213 
to -191 bp, region II spanned from -180 to -164 bp, and 
region III spamred from -61 to -33 bp. In contrast, only two 
protected regions, corresponding to the regions II and III, were 
identified on the coding and non-coding strands of the GNCP-2 
promoter using the 104Cl nuclear extracts (Figs. 4B and 5B). 
Interestingly, no protected regions were observed on either the 
GNCP-1 or the GNCP-2 promoters using neutrophil nuclear 
extracts. The GNCP genes are transcribed in 104Cl cells but 
not in mature neutrophils [ll]. Therefore, it is likely that nu- 
clear proteins which interact with the GNCP promoters are not 
expressed in the mature neutrophils. The locations of the pro- 
tected sequences are summarized in Fig. 6. There are several 
differences in the nucleotide sequences of the GNCP-1 and 
GNCP-2 promoters, and region I was not observed on the 
GNCP-2 promoter. On the other hand, regions II and III were 
identified on both the GNCP-1 and GNCP-2 promoters. Re- 
gion I is purine-rich and appears to contain a sequence (GAG- 
GAA) similar to the recognition site for the nuclear factor PU. 1 
which has an important role in regulating the myeloid-specific 
expression of the CD 11 b and lysozyme genes [ 17,181. Region 
II contains the glucocorticoid regulating element-like sequence 
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Fig. 5. DNase I footprint analysis of the GNCP-1 and GNCP-2 promoter regions (II). The coding and non-coding strands of the 270-bp fragments 
(-223 to +47 bp) of the GNCP-1 (A) and GNCP-2 (B) promoters were end-labeled, and further treated as described in the legend to Fig. 4. 
(AGAACAN,TGlTCT)[lS], and region III seems to contain 
the pyrimidine-rich sequence which is assumed to be a regula- 
tory element of the myeloperoxidase and neutrophil elastase 
genes [20]. 
As shown in Fig. 3, region I was present on the GNCP-1 
promoter but not on the GNCP-2 promoter, and the deletion 
of the sequences (-223 to -80 bp) containing region I resulted 
in a decrease of the promoter activity. Furthermore, a mutation 
of region I which had been introduced by replacing the GNCP- 
1 sequences with the GNCP-2 sequences, reduced the promoter 
activity nearly to the level of the GNCP-2 promoter (Fig. 3). 
Thus, region I appears to be a positive regulatory element for 
the GNCP-1 promoter. Region II was present on both the 
GNCP-I and GNCP-2 promoters. However, the deletion of 
region II did not affect the GNCP-2 promoter activity (Fig. 3), 
suggesting that region II is not important for the GNCP-2 
promoter. In cdntrast, the mutation of region II resulted in a 
2-fold decrease of the GNCP-1 promoter activity, suggesting 
that not only region I but also region II is involved in the 
difference in the promoter activities of GNCP-1 and GNCP-2. 
Region III was present on both the GNCP-1 and GNCP-2 
promoters, and the deletion of region III brought about the 
almost complete loss of the promoter activities. Furthermore, 
the S-upstream sequences (-223 to -80 bp) of the GNCP-1 and 
GNCP-2 promoters containing regions I and II or region II did 
not show significant promoter activity by themselves (Fig. 3). 
Together these observations indicate that region III might be 
a common regulatory element which is involved in the basal 
activities of the GNCP-1 and GNCP-2 promoters. 
Recently, we have found that neutrophils contain approxi- 
mately 2-fold more GNCP-1 than GNCP-2 [5]. In this study, 
we have shown that the promoter activity of GNCP-1 is 2-fold 
Fig. 6. Summary of DNase I footprint analysis. The nucleotide se- 
quences of the 5’-flanking regions of the GNCP-1 and GNCP-2 genes 
are shown from -223 to - 1 bp. Nucleotide sequences which aie differ- 
ent from those of GNCP-1, are boxed. The regions protected from 
DNase I digestion by the 104Cl nuclear extracts are indicated by 
horizontal lines for the coding and non-coding DNA strands above and 
below the nucleotide sequences, respectively. The three regions of pro- 
tein-DNA interactions are designated I-III. 
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greater than that of GNCP-2, although the nucleotide 
sequences of the two promoters are homologous. These obser- 
vations suggest that the difference in the expression of the 
GNCP-1 and GNCP-2 genes is likely regulated at the level of 
transcription. The GNCP gene is transcribed in the neutrophil 
precursor cells in the bone marrow but not in the mature neu- 
trophils [l 11. Analysis of nuclear protein factors interacting 
with the GNCP promoters will elucidate the transcriptional 
regulation of the GNCP genes during differentiation and mat- 
uration of the bone marrow progenitor cells. 
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